301 related articles for article (PubMed ID: 36171288)
1. PD-1 combination therapy with IL-2 modifies CD8
Hashimoto M; Araki K; Cardenas MA; Li P; Jadhav RR; Kissick HT; Hudson WH; McGuire DJ; Obeng RC; Wieland A; Lee J; McManus DT; Ross JL; Im SJ; Lee J; Lin JX; Hu B; West EE; Scharer CD; Freeman GJ; Sharpe AH; Ramalingam SS; Pellerin A; Teichgräber V; Greenleaf WJ; Klein C; Goronzy JJ; Umaña P; Leonard WJ; Smith KA; Ahmed R
Nature; 2022 Oct; 610(7930):173-181. PubMed ID: 36171288
[TBL] [Abstract][Full Text] [Related]
2. PD-1-cis IL-2R agonism yields better effectors from stem-like CD8
Codarri Deak L; Nicolini V; Hashimoto M; Karagianni M; Schwalie PC; Lauener L; Varypataki EM; Richard M; Bommer E; Sam J; Joller S; Perro M; Cremasco F; Kunz L; Yanguez E; Hüsser T; Schlenker R; Mariani M; Tosevski V; Herter S; Bacac M; Waldhauer I; Colombetti S; Gueripel X; Wullschleger S; Tichet M; Hanahan D; Kissick HT; Leclair S; Freimoser-Grundschober A; Seeber S; Teichgräber V; Ahmed R; Klein C; Umaña P
Nature; 2022 Oct; 610(7930):161-172. PubMed ID: 36171284
[TBL] [Abstract][Full Text] [Related]
3. Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
Mariniello A; Nasti TH; Chang DY; Hashimoto M; Malik S; McManus DT; Lee J; McGuire DJ; Cardenas MA; Umana P; Nicolini V; Antia R; Saha A; Buchwald Z; Kissick H; Ghorani E; Novello S; Sangiolo D; Scagliotti GV; Ramalingam SS; Ahmed R
Clin Cancer Res; 2024 May; 30(9):1833-1845. PubMed ID: 37992307
[TBL] [Abstract][Full Text] [Related]
4. Harnessing CD8 T cell responses using PD-1-IL-2 combination therapy.
Hashimoto M; Ramalingam SS; Ahmed R
Trends Cancer; 2024 Apr; 10(4):332-346. PubMed ID: 38129234
[TBL] [Abstract][Full Text] [Related]
5. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
Jadhav RR; Im SJ; Hu B; Hashimoto M; Li P; Lin JX; Leonard WJ; Greenleaf WJ; Ahmed R; Goronzy JJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14113-14118. PubMed ID: 31227606
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.
West EE; Jin HT; Rasheed AU; Penaloza-Macmaster P; Ha SJ; Tan WG; Youngblood B; Freeman GJ; Smith KA; Ahmed R
J Clin Invest; 2013 Jun; 123(6):2604-15. PubMed ID: 23676462
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
[TBL] [Abstract][Full Text] [Related]
9. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
[TBL] [Abstract][Full Text] [Related]
10. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
Front Immunol; 2022; 13():869768. PubMed ID: 35774790
[TBL] [Abstract][Full Text] [Related]
11. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
Hashimoto M; Kamphorst AO; Im SJ; Kissick HT; Pillai RN; Ramalingam SS; Araki K; Ahmed R
Annu Rev Med; 2018 Jan; 69():301-318. PubMed ID: 29414259
[TBL] [Abstract][Full Text] [Related]
12. IL2Rβ-dependent signals drive terminal exhaustion and suppress memory development during chronic viral infection.
Beltra JC; Bourbonnais S; Bédard N; Charpentier T; Boulangé M; Michaud E; Boufaied I; Bruneau J; Shoukry NH; Lamarre A; Decaluwe H
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5444-53. PubMed ID: 27573835
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
14. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Votavova P; Tomala J; Kovar M
Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
[TBL] [Abstract][Full Text] [Related]
15. Role of PD-1 during effector CD8 T cell differentiation.
Ahn E; Araki K; Hashimoto M; Li W; Riley JL; Cheung J; Sharpe AH; Freeman GJ; Irving BA; Ahmed R
Proc Natl Acad Sci U S A; 2018 May; 115(18):4749-4754. PubMed ID: 29654146
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral Tcf1
Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
[TBL] [Abstract][Full Text] [Related]
17. Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion.
Alvarez M; Simonetta F; Baker J; Morrison AR; Wenokur AS; Pierini A; Berraondo P; Negrin RS
Front Immunol; 2020; 11():7. PubMed ID: 32117218
[TBL] [Abstract][Full Text] [Related]
18. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection.
Blattman JN; Wherry EJ; Ha SJ; van der Most RG; Ahmed R
J Virol; 2009 May; 83(9):4386-94. PubMed ID: 19211743
[TBL] [Abstract][Full Text] [Related]
19. Subsets of exhausted CD8
Miller BC; Sen DR; Al Abosy R; Bi K; Virkud YV; LaFleur MW; Yates KB; Lako A; Felt K; Naik GS; Manos M; Gjini E; Kuchroo JR; Ishizuka JJ; Collier JL; Griffin GK; Maleri S; Comstock DE; Weiss SA; Brown FD; Panda A; Zimmer MD; Manguso RT; Hodi FS; Rodig SJ; Sharpe AH; Haining WN
Nat Immunol; 2019 Mar; 20(3):326-336. PubMed ID: 30778252
[TBL] [Abstract][Full Text] [Related]
20. Transcription Factor IRF4 Promotes CD8
Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]